Current strategies for the treatment of hereditary angioedema (HAE) includetargeted inhibition or antagonism of the contact system, which is dysregulatedin HAE patients by a C1 esterase inhibitor deficiency. This evidence concerns the gene C1S and hereditary angioedema.